Antag's Incubator/Accelerator Round

Antag raised a round of funding on February 15, 2017. Investors include Accelerace.

Antag has developed a novel anti-obesity treatment based on a highly potent inhibitor of a hormone involved in fat accumulation. Essentially, Antag provides hormone treatment to fight obesity.…

Articles about Antag's Incubator/Accelerator Round: